Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

E.C. Dijkers, T.H.O. Munnink, J.G. Kosterink, A.H. Brouwers, P.L. de Jager, J.R. de Jong, G.A.M.S. van Dongen, C.P. Schroder, M.N. Lub-de Hooge, E.G.E. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)586-592
JournalClinical Pharmacology & Therapeutics
Volume87
Issue number5
DOIs
Publication statusPublished - 2010

Cite this

Dijkers, E. C., Munnink, T. H. O., Kosterink, J. G., Brouwers, A. H., de Jager, P. L., de Jong, J. R., ... de Vries, E. G. E. (2010). Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer. Clinical Pharmacology & Therapeutics, 87(5), 586-592. https://doi.org/10.1038/clpt.2010.12